$14.20
0.392.82%
At close: -
$14.20
0.000.00%
After Hours: 4:24 PM EDT
Comments
Loading...
Denali Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:DNLI | Benzinga
Denali Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.820
Quarterly Revenue Estimate
$5.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Denali Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics | -$0.68 | -$0.82 | — | — | $0.00 | $5.00M | — | — | 05/06/2025 | Get Alert |
| DNLI | Denali Therapeutics | -$0.86 | -$0.91 | -$0.67 | 26.37% | $0.00 | $12.58M | $0.00 | -100.00% | 02/27/2025 | Get Alert |
| DNLI | Denali Therapeutics | -$0.72 | -$0.61 | -$0.63 | -3.28% | $1.27M | $9.45M | $0.00 | -100.00% | 11/06/2024 | Get Alert |
| DNLI | Denali Therapeutics | $1.30 | -$0.68 | -$0.59 | 13.24% | $294.12M | $15.04M | $0.00 | -100.00% | 08/01/2024 | Get Alert |
| DNLI | Denali Therapeutics | -$0.80 | -$0.70 | -$0.68 | 2.86% | $35.14M | $14.02M | $0.00 | -100.00% | 05/07/2024 | Get Alert |
| DNLI | Denali Therapeutics | -$0.75 | -$0.80 | -$0.86 | -7.50% | $10.28M | $8.36M | $0.00 | -100.00% | 02/27/2024 | Get Alert |
| DNLI | Denali Therapeutics | -$0.84 | -$0.82 | -$0.72 | 12.20% | $3.56M | $10.80M | $1.27M | -88.27% | 11/07/2023 | Get Alert |
| DNLI | Denali Therapeutics | -$0.48 | -$0.68 | $1.30 | 291.18% | $52.48M | $13.46M | $294.12M | 2085.16% | 08/08/2023 | Get Alert |
| DNLI | Denali Therapeutics | -$0.53 | -$0.70 | -$0.80 | -14.29% | $42.14M | $28.72M | $35.14M | 22.36% | 05/08/2023 | Get Alert |
| DNLI | Denali Therapeutics | -$0.62 | -$0.79 | -$0.75 | 5.06% | $12.50M | $13.12M | $10.28M | -21.62% | 02/27/2023 | Get Alert |
| DNLI | Denali Therapeutics | -$0.69 | -$0.81 | -$0.84 | -3.70% | $5.29M | $14.47M | $3.56M | -75.40% | 11/03/2022 | Get Alert |
| DNLI | Denali Therapeutics | -$0.50 | -$0.55 | -$0.48 | 12.73% | $22.94M | $43.90M | $52.48M | 19.54% | 08/08/2022 | Get Alert |
| DNLI | Denali Therapeutics | -$0.58 | -$0.51 | -$0.53 | -3.92% | $7.92M | $25.69M | $42.14M | 64.04% | 05/05/2022 | Get Alert |
| DNLI | Denali Therapeutics | $1.91 | — | -$0.62 | — | $316.81M | — | $12.51M | — | 02/28/2022 | Get Alert |
| DNLI | Denali Therapeutics | -$0.54 | -$0.47 | -$0.69 | -46.81% | $9.39M | $30.28M | $5.29M | -82.55% | 11/04/2021 | Get Alert |
| DNLI | Denali Therapeutics | -$0.56 | -$0.40 | -$0.50 | -25.00% | $5.85M | $29.35M | $22.94M | -21.84% | 08/04/2021 | Get Alert |
| DNLI | Denali Therapeutics | -$0.55 | — | -$0.58 | — | $3.60M | — | $7.92M | — | 05/03/2021 | Get Alert |
| DNLI | Denali Therapeutics | -$0.56 | — | $1.91 | — | $4.67M | — | $316.81M | — | 02/25/2021 | Get Alert |
| DNLI | Denali Therapeutics | -$0.48 | — | -$0.54 | — | $13.60M | — | $9.39M | — | 11/05/2020 | Get Alert |
| DNLI | Denali Therapeutics | -$0.61 | — | -$0.56 | — | $4.20M | — | $5.85M | — | 08/07/2020 | Get Alert |
| DNLI | Denali Therapeutics | -$0.41 | — | -$0.55 | — | $4.21M | — | $3.60M | — | 05/07/2020 | Get Alert |
Denali Therapeutics (DNLI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.67 | $-0.91 | 26.4 % |
| Q3 | 2024-11-06 | $-0.63 | $-0.61 | -3.28 % |
| Q2 | 2024-08-01 | $-0.59 | $-0.68 | 13.2 % |
| Q1 | 2024-05-07 | $-0.68 | $-0.70 | 2.86 % |
Denali Therapeutics (DNLI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0 | $12.58M | -100.0 % |
| Q3 | 2024-11-06 | $0 | $9.45M | -100.0 % |
| Q2 | 2024-08-01 | $0 | $15.04M | -100.0 % |
| Q1 | 2024-05-07 | $0 | $14.02M | -100.0 % |
FAQ
When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?
Denali Therapeutics (DNLI) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Denali Therapeutics (NASDAQ:DNLI)?
The Actual EPS was $-0.67, which beat the estimate of $-0.91.
What were Denali Therapeutics’s (NASDAQ:DNLI) revenues?
The Actual Revenue was $0K, which missed the estimate of $12.6M.
Browse earnings estimates, EPS, and revenue on all stocks.